Blocking autophagy enhances meloxicam lethality to hepatocellular carcinoma by promotion of endoplasmic reticulum stress

OBJECTIVES: Meloxicam, a selective cyclooxygenase‐2 (COX‐2) inhibitor, has been demonstrated to exert anti‐tumour effects against various malignancies. However, up to now, mechanisms involved in meloxicam anti‐hepatocellular carcinoma effects have remained unclear. MATERIALS AND METHODS: Cell viabil...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cell Prolif
Egile Nagusiak: Zhong, Jingtao, Dong, Xiaofeng, Xiu, Peng, Wang, Fuhai, Liu, Ju, Wei, Honglong, Xu, Zongzhen, Liu, Feng, Li, Tao, Li, Jie
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2015
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6496225/
https://ncbi.nlm.nih.gov/pubmed/26481188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12221
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak